BARCELONA (Reuters) - Sales forecasts for Novartis’s new heart failure drug are being ramped up by analysts after strikingly good clinical trial results for a medicine doctors expect to transform treatment of the deadly disease. Shares in the Swiss drugmaker jumped over 3 percent to a record…
Source: 'Most exciting ever' Novartis drug points to huge sales
Monday, September 1, 2014
'Most exciting ever' Novartis drug points to huge sales
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment